Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials (Q3842893): Difference between revisions

@@ Property / MaRDI profile type @@
+MaRDI publication profile
@@ Property / MaRDI profile type: MaRDI publication profile / rank @@
+Normal rank
@@ Property / full work available at URL @@
+https://doi.org/10.1080/03610929808832163
+Normal rank
@@ Property / OpenAlex ID @@
+W2062627724
@@ Property / OpenAlex ID: W2062627724 / rank @@
+Normal rank
@@ Property / cites work @@
+A Two-Stage Procedure for Survival Studies with Surrogate Endpoints
+Normal rank
@@ Property / cites work @@
+Using surrogate failure time data to increase cost effectiveness in clinical trials
+Normal rank
@@ Property / cites work @@
+A Stochastic Model for Censored-Survival Data in the Presence of an Auxiliary Variable
+Normal rank
@@ Property / cites work @@
+Inference using surrogate outcome data and a validation sample
+Normal rank
@@ Property / cites work @@
+Analyzing survival data in conjunction with time-dependent surrogate endpoints in clinical trials
+Normal rank